publication venue for
- The origin of the four major focus of HTLV-1 in Latin America 2024
- Antiretroviral Therapy for HIV-2 Infection in Non-Endemic Regions. 44-56. 2020
- COVID-19 Comes 40 Years After AIDS - Any Lesson?. 63-77. 2020
- Statins in HIV-Infected Patients: Potential Beneficial Effects and Clinical Use. 59-71. 2017
- Impact of ART including coreceptor inhibitor (maraviroc) on liver stifness in cirrhotic coinfected HIV/HCV patients. HEFICO sub-study. 51-52. 2015
- HIV-2 and HTLV-1 infections in Spain, a non-endemic region... 152-159. 2014
- Renal Tubular Transporter-Mediated Interactions of HIV Drugs: Implications for Patient Management.. 199-212. 2014
- Update on Clinical and Methodological Recommendations for Genotypic Determination of HIV tropism to Guide the Usage of CCR5 Antagonists. 208-217. 2012
- The role of HIV and antiretroviral therapy in bone disease. 109-118. 2011
- Genotypic determination of HIV tropism - clinical and methodological recommendations to guide the therapeutic use of CCR5 antagonists. . 135-148. 2010
- HIV Infection and Aging. 218-230. 2010
- Pharmacogenetics of adverse effects due to antiretroviral drugs.. 15-30. 2010
- Disorders of body fat distribution in HIV-1-infected patients.. 126-134. 2009
- HIV-1 genotypic drug resistance interpretation rules - 2009 Spanish guidelines. 39-51. 2009